XML 66 R51.htm IDEA: XBRL DOCUMENT v2.4.0.6
SETTLEMENT WITH HERBAL SCIENCE (Details) (USD $)
In Millions, except Share data, unless otherwise specified
3 Months Ended 12 Months Ended 12 Months Ended 12 Months Ended
Jun. 30, 2011
Dec. 31, 2011
Dec. 31, 2010
Dec. 31, 2012
Mar. 31, 2011
Dec. 31, 2011
Rice Rx, LLC (RRX) [Member]
Dec. 31, 2010
Rice Rx, LLC (RRX) [Member]
Jun. 30, 2011
Rice Rx, LLC (RRX) [Member]
Mar. 31, 2011
Rice Rx, LLC (RRX) [Member]
Dec. 31, 2012
Rice Science, LLC (RS) [Member]
Dec. 31, 2011
Rice Science, LLC (RS) [Member]
Jun. 30, 2011
Rice Science, LLC (RS) [Member]
Mar. 31, 2011
Rice Science, LLC (RS) [Member]
Loss Contingencies [Line Items]                          
Proof of claim     $ 1.5                    
Stipulated settlement agreement     0.9                    
Cash payments of obligations   0.4                      
Remaining balance of obligation         0.5                
Stock issued as settlement (in shares) 2,576,775                        
Warrants issued as a part of the settlement (in shares) 605,730                        
Exercise price of warrants granted (in dollars per share) $ 0.23 $ 1.13   $ 0.31                  
Fair value of common stock and warrant issued in excess of obligation to buyer 0.2                        
Fair value of stock issued 0.6                        
Fair value of warrants issued 0.1                        
Ownership interest in equity investee (in hundredths)               100.00% 50.00%     100.00% 80.00%
Satisfaction of liabilities from equity investees   0.6                      
Payment of interest on liabilities   0.1                      
Attorneys fees   0.1                      
Additional ownership interest in equity investees   0.1                      
Payment of liabilities of equity investees   0.3                      
Cash paid for equity investee's interest and the noncontrolling interest derecognized with the transaction   0.3                      
Gain (loss) on increased ownership interests and net liabilities assumed   0       (0.1)         0    
Loss from operations of investee           $ 0 $ 0     $ 0 $ 0